2017header

2017 Annual PRE-Conference Patient / Caregiver Q&A Session

Are you going to the CCF Annual Conference?

If so, please take a moment to listen to our pre-conference Question & Answer Session. We discussed what you can expect at the conference, including: Hotel, Agenda, Networking opportunities, Dress code, and the Sightseeing Tour of Salt Lake City.

LISTEN NOW


Save the Date

Cholangiocarcinoma Foundation Annual Conference
January 31-February 2, 2018
Salt Lake City, Utah


This annual program seeks to develop sustainable participation of the medical and research communities in the field of cholangiocarcinoma by providing a forum to:

  • Increase the knowledge of attendees about key issues central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma
  • Present a diversity of perspectives focused on clinical, basic, and translational research
  • Stimulate multi-disciplinary, cross-institutional collaborations
  • Foster dialogue and inspire innovation

Further, because patients living with cholangiocarcinoma have a direct stake in their own medical care and are in a unique position to provide input, CCF has expanded its Annual Conference to include programming that addresses questions and concerns that are important to patients and their families. Patients and caregivers—having experienced the disease firsthand—will be invited to learn about cholangiocarcinoma, share their personal experiences, and contribute to future efforts to further cholangiocarcinoma research.


Conference Chairs

Aram Hezel, MD

Juan Valle, MB ChB MSc FRCP


Who Should Attend?

  • Researchers
  • Physicians
  • Oncologists
  • Radiologists
  • Surgeons
  • Gastroenterologists
  • Hepatologists
  • Nurses specializing in oncology, intensive care, and palliative care
  • Pharmaceutical Companies
  • Government Regulators
  • Policymakers
  • Patients, Caregivers and others invested in the field of cholangiocarcinoma

A special thank you to our event supporters to date:

OAK LEVEL

Screen Shot 2017-01-17 at 11.12.37 PMIgnyta Ad Genome Update with Bleed V3
Incyte_2CPos_RGBMerck green and grey
 


CEDAR LEVEL

Screen Shot 2017-01-17 at 11.24.33 PMPrint
 


MAPLE LEVEL

Screen Shot 2017-01-17 at 10.54.12 PMScreen Shot 2017-01-17 at 10.54.46 PMaslanBristol-Myers Squibb LogoScreen Shot 2017-01-17 at 11.28.22 PM Screen Shot 2017-01-17 at 11.28.28 PMScreen Shot 2017-01-17 at 11.00.28 PMPCI-logo-EPS-vektorisert-[Converted]Screen Shot 2017-01-17 at 11.01.56 PMScreen Shot 2017-01-17 at 11.02.32 PMScreen Shot 2017-01-17 at 11.03.22 PM
 


ASPEN LEVEL

Boston Scientific

dōTERRA


PINE LEVEL

Promotion in Motion

University of Utah


Funding for this conference was made possible (in part) by 1R13CA213778-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Funding for this conference was made possible (in part) by a Eugene Washington Engagement Award from the Patient-Centered Outcomes Research Institute (PCORI) allowing 25 patients and caregivers from around the world to take part in all facets of the conference including speaking, attending sessions, roundtable discussions, and networking events.